The Valley Desk

ArticleImmuno-oncology technologyPublished

A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Immuno-oncology technology
Published
Subject terms
Fibroblast Growth factor Receptor 1; Immune Checkpoint Inhibitors; Immunotargeted Therapy; Anti-fgfr1 Monoclonal Antibody
PubMed ID
39290712
PubMed Central ID
PMC11403241
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal